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Camptothecin, a topoisomerase I inhibitor, is a well-
known anticancer drug. However, its mechanism has 
not been well studied in human gastric cancer cell 
lines. Camptothecin induced apoptotic cell death in 
human gastric cancer cell line AGS. Z-VAD-fmk, pan-
caspase inhibitor, blocked apoptotic phenotypes in-
duced by camptothecin suggesting that caspases are 
involved in camptothecin-induced cell death. An in-
hibitor of caspase-6 or -8 or -9 did not prevent cell 
death by camptothecin. Various protease inhibitors 
failed to prevent camptothecin-induced cell death. 
These results suggest that only few caspases are in-
volved in camptothecin-induced cell death. Campto-
thecin induced phosphorylation of ERK1/2, JNK, and 
p38 MAPK, in a dose and time-dependent manner in 
AGS. Z-VAD-fmk did not affect MAPK signaling in-
duced by camptothecin suggesting that caspase signal-
ing occurs downstream of MAPK signaling. Blocking 
of p38 MAPK, but not ERK1/2, resulted in partial in-
hibition of cell death and PARP cleavage by campto-
thecin in AGS. Taken together, MAPK signaling is as-
sociated with apoptotic cell death by camptothecin.  
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Introduction 
 
Camptothecin, a pentacyclic alkaloid isolated from the 
Chinese tree Camptotheca acuminata, was reported to 
have a potent antitumor activity (Hsiang et al., 1985). 
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Camptothecin has known to be an anticancer drug (Daoud 
et al., 1995). It was reported that antitumor activity of 
camptothecin was based on its inhibitory effect on topoi-
somerase activity. Camptothecin (inhibitor of topoisom-
erase I) stabilizes transient intermediate of topoisomerase 
reaction. In doing so, it produces DNA single or double 
strand breaks.  
   Camptothecin activates caspases and causes apoptosis 
(Barry et al., 1990). Apoptosis is a physiological process 
of cell death that plays a role in normal development as 
well as in the physiology of a variety of diseases. In an 
effort to understand mechanism of cell death by campto-
thecin, we studied the role of several molecules that are 
assumed to play a role in apoptosis. These include p21, 
caspases, PARP1, and MAPK. P21 (Waf1/Cip1) report-
edly acts as an inhibitory regulator of caspase-3 activity 
(Asada et al., 1999). It acts by binding to procaspase-3 
(Suzuki et al., 1999). It also reportedly protected apop-
tosis mediated by p53 (Gorospe et al., 1997). Caspases 
are known to be proteases that are activated during apop-
tosis and sequential activation of these caspases cleaves 
various cellular substrates. So far, 14 mammalian cas-
pases have identified. Among these caspases 3, 6, and 7 
are known to be primary execution caspases during apop-
tosis (Slee et al., 2001).  
   Experiments using immune-depleted cell free extracts 
showed that caspase-3 cleaves a variety of substrates in-
cluding inositol 1,4,5-triphosphate receptor (Haug et al., 
2000), gelsolin (Kothakota et al., 1997), and PARP. PARP 
is a well-known substrate of caspase-3 and is cleaved dur-
ing apoptosis (Kaufmann et al., 1993; Oliver et al., 1998).  
 
Abbreviations: MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromid; PARP, poly (ADP-ribose) polymerase; Z-VAD- 
fmk, benzyloxylcarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone. 
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Lack of PARP cleavage led to an induction of necrosis 
(Herceg and Wang, 1999). 
   MAPKs are activated by a plethora of extracellular 
stimuli. There are four classes of MAPKs: ERK1/2, 
JNK1/2, p38 proteins, and ERK5. MAPKs play important 
role in diverse cellular processes such as cell proliferation 
and apoptosis (Graves et al., 2000). Activation of ERK1/2 
is associated cellular proliferation, while p38 proteins and 
JNKs are involved in apoptosis (Xia et al., 1995). Here 
we report molecular mechanism of cell death by campto-
thecin in human gastric cancer cell line, AGS.  
 
 
Materials and Methods  
 
Materials Camptothecin, SB203580, and PD98059 were ob-
tained from Sigma Chemical Company (USA). Primary antibod-
ies to p21, PARP, caspase-8, and caspase-3 were obtained form 
Upstate Biotechnology Inc. (USA). Primary antibodies to ERK/ 
phospho-ERK, p38 MAPK/phospho-p38 MAPK, and JNK/ 
phospho-JNK were all obtained from NEB Company (USA). 
Caspase-3 and -8 activity assay kits were obtained from 
Promega (USA). Caspase inhibitors z-VAD-fmk, z-VEID-fmk, 
z-LEHD-fmk and z-IETD-fmk were obtained from CN Biosci-
ences, Inc. (Germany). All protease inhibitors used in this study 
were obtained from Sigma Chemical Company. MTT assay kit 
was obtained from Roche Diagnostics GmbH (Germany).  
 
Cell culture Gastric cancer cell line used in this study is AGS. 
This cell line was obtained from Korea Cell Line Bank (Korea). 
This cell line was grown in RPMI medium containing 10% FBS 
at 37°C in a humidified atmosphere containing 5% CO2.  
 
Western blot analysis Total cell lysate was isolated according 
to the standard procedures. Briefly, 20 µg of total cell lysates 
were loaded onto 10% SDS-PAGE. Loaded proteins were run 
and transferred onto immobilon-p membrane by electro blot 
transfer at 4°C with 50 mA for 2 h. Membrane containing trans-
ferred proteins was washed twice with 1× PBS-T buffer (PBS, 
0.1% Tween 20). Membrane was incubated with blocking buffer 
(1× PBS, 4% Skim milk, 0.1% Tween 20) for 1 h at room tem-
perature. After washing with PBS-T buffer, membrane was in-
cubated with primary antibody in blocking buffer for 1 h at 
room temperature. After washing with PBS-T buffer, membrane 
was incubated with HRP-conjugated secondary antibody in 
blocking buffer at a dilution of 1:3,000. ECL-plus kit was used 
for detection of protein of interest. Primary antibodies to both 
ERK and phospho-ERK were used in a 1:1,000 dilution. Pri-
mary antibodies to p38 MAPK and phospho-p38 MAPK were 
used in a 1:500 dilution. Primary antibodies to JNK and phos-
pho-JNK were both used at a concentration of 1 µg/ml. 
 
Annexin V-FITC staining Cells (5 × 105) were centrifuged at 
800 × g for 3 min. Cell pellets were washed with cold PBS 
buffer twice and resuspended in binding buffer [10 mM Hepes 
(pH 7.4), 140 mM NaCl, 2.5 mM CaCl2,]. A hundred µl of the 
solution was transferred to 5 ml culture tube. To this, annexin 
V-FITC (200 ng/ml) and PI (200 ng/ml) were added. Cells were 
vortexed and incubated for 15 min at room temperature in the 
dark. To this, 400 µl of binding buffer was added and FACS 
analysis was carried out.  
 
DNA fragmentation Cells (5 × 105) were harvested and put into 
microcentrifuge tube. To this, 300 µl of lysis buffer (27% su-
crose, 1× SSC, 1 mM EDTA, and 1% SDS) was added. 30 µg of 
RNase A was added and incubation continued at 37°C for 1 h. 
After incubation, proteinase K (100 µg/ml) was added and incu-
bation continued for 3 h at 50°C. Equal volume of phe-
nol/chloroform/ isoamyl alcohol was added, and mixed for 10 
min. Tube was centrifuged for 10 min at 2,500 × g. Aqueous 
phase was saved and 10 mM MgCl2 (final concentration) was 
added. After this, 2 volumes of ethanol were added and cen-
trifugation at 2,500 × g for 15 min was followed. Tube was 
washed with 70% ethanol and the pellet was dissolved in DDW. 
Thus, obtained DNA was analyzed on 2% agarose gel. 
 
Caspase activity assay Caspase-3 or -8 activity assay was done 
according to the instruction manual provided by the manufac-
turer (Promega, USA). Ten µg of cell lysates was subjected to 
caspase-3 or caspase-8 activity assay. Caspase-3 or -8 activities 
were measured at 405 nm by using 96 well micro plate readers.  
 
 
Results 
 
Induction of apoptosis by camptothecin To determine 
whether camptothecin induced apoptotic cell death, we 
carried out annexin V-FITC/PI staining to quantitate cell 
death by camptothecin. As shown in Fig. 1A, camptothe-
cin induced apoptosis in AGS. We checked whether 
camptothecin induced DNA fragmentation. As shown in 
Fig. 1B, camptothecin treatment caused DNA fragmenta-
tion in AGS in a time-dependent manner. PARP is an 
abundant, chromatin-associated enzyme, which is be-
lieved to be important for genome stability (Simbulan-
Rosenthal et al., 1999). PARP cleavage occurred in a dose 
and time-dependent manner (Figs. 1C and 1D). PARP was 
cleaved into 85 kDa fragment typical of apoptosis.  
   We checked whether camptothecin-induced cell death 
related to caspase activity. It is well known fact that cas-
pases are required for apoptosis (Kuida et al., 1996). To 
check whether camptothecin affects caspase-3 and -8, we 
carried out Western blot analysis. As shown in Fig. 2A, 
camptothecin caused processing of procaspase-3 and -8. 
This suggests that camptothecin directly affects caspase-8. 
Procaspase-3 processing also occurred in AGS (Fig. 2A). 
However, processing of procaspase-9 was not found in 
response to camptothecin (data not shown).  
   We carried out caspase activity assays of AGS cell. 
Camptothecin induced caspase-3 and -8 activities in a 
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Fig. 1. Camptothecin induces apoptosis. (A) Annexin V-FITC 
staining of AGS treated with camptothecin (1 µM) for various 
time intervals. At each time point, cells were subjected to FACS 
analysis using annexin V-FITC (20 µg/ml) and propidium io-
dide (50 µg/ml) was carried out. Lower right hand quadrant 
represents cells undergoing apoptosis, and upper left hand quad-
rant represents cells undergoing necrosis. Numbers represent 
cells undergoing apoptosis (B) DNA fragmentation by campto-
thecin. AGS was treated with camptothecin (1 µM) and DNA at 
each time point was isolated. DNA was loaded on 1.2% agarose 
gel. Camptothecin caused PARP cleavage in a dose and time-
dependent manner (C and D). Western blot analysis using poly-
clonal anti PARP antibody was carried out as described in Ma-
terials and Methods. 
 
 
dose and time-dependent manner (Fig. 2B). Kinetics 
study showed that induction of caspase-3-like and -8 ac- 
tivities occurred simultaneously. Caspase-3-like activity 
showed much higher activity than that of caspase-8. The 
induction of both caspase-3-like and -8 activities occurred 
as early as 6 h of camptothecin treatment. This suggests 
that elevated level of caspase activity is responsible for 
camptothecin-induced cell death. Taken together, these 
results suggest camptothecin induces apoptotic pheno-
types in this cell.  
 
The effect of caspase inhibitors on apoptotic pheno-
types and cell death We determined whether apoptotic 
cell death by camptothecin required caspases. Z-VAD-
fmk, a pan-caspase inhibitor and z-DEVE-fmk, an inhibi- 
  A 
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Fig. 2. Camptothecin induces caspase-3 and -8 activity. Campto-
thecin caused procaspase-8 and -3 processing (A) AGS was 
treated with camptothecin (1 µM) for various time intervals. 
Western blot analysis using polyclonal anti procaspase-8 or -3 
antibody was carried out. (B) Camptothecin induces both cas-
pase-3-like and -8 activities. Caspase-3 and -8 activity assays 
were carried out according to the instruction manual (Promega, 
USA). AGS was treated with camptothecin (1 µM) for various 
concentrations and time intervals (0, 0.5, 1, 3, 6, and 9 h). Ac-
IETD-pNA was used as substrate for caspase-8 and Ac-DEVD-
pNA was used as substrate for caspase-3.  
 
 
tor of caspase-3, prevented DNA fragmentation by camp-
tothecin in AGS. However, z-IETD-fmk, an inhibitor of 
caspase-8, partially inhibited DNA fragmentation induced 
by camptothecin in AGS (Fig. 3A). Annexin V-FITC 
staining showed that z-VAD-fmk inhibited apoptotic cell 
death in AGS effectively (Fig. 3B). Proteases inhibitors, 
including PMSF, also inhibited apoptotic cell death (Fig. 
3B). This implies that some of these proteases are at least 
partially responsible for apoptotic cell death by campto-
thecin. To identify specific caspase or protease that medi- 
 Seongeun Lee et al. 351 
 
 A 
 
 
 
 
 
 
 
 B 
 
 
 
 
 
 C 
 
 
 
 
 
 
 
 D 
 
 
 
 
 
 
Fig. 3. The effect of caspase inhibitors on apoptotic phenotypes 
and cell death. Z-VAD-fmk blocks DNA fragmentation in AGS 
(A) AGS was treated with camptothecin in the absence or pres-
ence of z-VAD-fmk, z-DEVD-fmk or z-IETD-fmk. Genomic 
DNA isolated from AGS was run on 1.2% agarose gel electro-
phoresis. Z-VAD-fmk blocks apoptotic cell death induced by 
camptothecin in AGS (B) AGS was incubated with camptothe-
cin (1 µM) in the absence or presence of caspase inhibitor z-
VAD-fmk (50 µM) and various proteases inhibitors. Concentra-
tions of these inhibitors were the same as those in Fig. 3C. An-
nexin V-FITC/PI staining was carried out as descried in Fig. 1A. 
(C) AGS was incubated with camptothecin (1 µM) in the ab-
sence or presence of various caspase inhibitors or protease in-
hibitors for 24 h. MTT assay was carried out. (D) AGS was 
incubated with camptothecin (1 µM) in the absence or presence 
of caspase inhibitor z-VAD-fmk (50 µM) or z-IETD-fmk for 24 
h. These inhibitors were pretreated for 3 h before camptothecin 
treatment. Western blot analysis of PARP was carried out as 
described before.  
 
 
ates camptothecin-induced cell death, AGS was incubated 
with camptothecin in the absence or presence of various 
inhibitor of caspase or protease. Various inhibitors of pro-
teases and inhibitors of caspase-6, -8 or -9 did not affect 
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Fig. 4. The effect of camptothecin on MAPK signaling. A. AGS 
was treated with camptothecin (1 µM) in the absence or pres-
ence of SB203580 or PD98059. After 1 d of treatment, MTT 
assay was carried out. AGS was preincubated with SB203580 (1 
µM) or PD98059 (10 µM) for 2 h before camptothecin treatment. 
B. AGS was treated with camptothecin (1 µM) for various time 
intervals. At each time point, cell lysates were prepared and 
Western blot analysis was carried out. Western blot analysis 
using phospho antibodies to ERK1/2 or p38 MAPK or JNK was 
carried out. C. AGS was treated with various concentrations of 
camptothecin for 1 h. Western blot analysis was carried out as 
described before. D. AGS was treated with camptothecin (1 µM) 
in the absence or presence of SB203580 (1 µM) or PD98059 (10 
µM) or z-VAD-fmk (50 µM). Western blot analysis was carried 
out as described before. AGS was pretreated with SB203580 or 
PD98059 or z-VAD-fmk for 2 h, and incubation with campto-
thecin for 2 h was followed. E. AGS was treated with campto-
thecin (1 µM) in the absence or presence of SB203580 (1 µM) 
or PD98059 (10 µM). SB203580 or PD98059 was added 2 h 
before camptothecin treatment. Western blot analysis using 
polyclonal anti-procaspase-8 antibody or PARP was carried out.  
 
 
cell death by camptothecin (Fig. 3C). Z-VAD-fmk pre-
vented cell death by camptothecin (Fig. 3C). This sug-
gests that only few caspases are involved in cell death by 
camptothecin. Next, to check whether other apoptotic 
features are also blocked by z-VAD-fmk, AGS was 
treated with camptothecin in the absence or presence of z-
VAD-fmk. As shown in Fig. 3D, there was an inhibition 
of PARP cleavage by z-VAD-fmk in AGS. This suggests 
that PARP cleavage is a downstream target of caspase-3- 
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Fig. 5. Induction of p21 and its relationship with MAPK signal-
ing. AGS was treated with various concentrations of camptothe-
cin (A) or various time intervals (B) Western blot analysis using 
polyclonal anti-p21 was carried out. (C) Induction of p21 is 
related to MAPK signaling. AGS was treated with camptothecin 
(1 µM) in the absence or presence of SB203580 or PD98059. 
Western blot analysis was carried out.  
 
 
like activities. AGS was treated with camptothecin in the 
absence or presence of z-IETD-fmk to check whether 
inhibition of caspase-8 affects PARP cleavage. As shown 
in Fig. 3D, z-IETD-fmk partially inhibited PARP cleavage 
induced by camptothecin in AGS. This suggests that cas-
pase-8 at least partially modulates caspase-3-like activi-
ties in AGS.  
 
The induction of MAPK signaling by camptothecin We 
were interested in the early events of camptothecin-
induced cell death. We focused on MAPK signaling. 
MAPK signaling is known to be associated with many 
aspects of regulation of cellular growth. To check whether 
MAPK signaling had any relationship with camptothecin-
induced cell death, AGS was incubated with camptothecin 
in the absence or presence of PD98059 (inhibitor of 
ERK1/2) or SB203580 (inhibitor of p38 MAPK). In MTT 
assay, PD98059 did not affect cell death by camptothecin 
(Fig. 4A). However, SB203580 partially attenuated cell 
death by camptothecin in AGS. This suggests that p38 
MAPK, but not ERK1/2, is at least partially responsible 
for camptothecin-induced cell death in AGS. To deter-
mine whether camptothecin induced MAPK signaling, 
AGS was treated with camptothecin (1 µM) for various 
time intervals or various concentrations and western blot 
analysis was carried out. As shown in Figs. 4B and 4C, 
camptothecin induced phosphorylation of ERK1/2 and 
p38 MAPK in a time and dose-dependent manner. The 
phosphorylation of ERK1/2 occurred as early as 30 min 
after treatment and at 0.1 µM or higher concentration of 
camptothecin. (Figs. 4B and 4C). Phosphorylation of JNK 
by camptothecin was detected in AGS (Figs. 4B and 4C). 
We checked whether z-VAD-fmk affects phosphorylation 
MAPK. As shown in Fig. 4D, z-VAD-fmk did not affect 
phosphorylation of MAPK in AGS. This suggests that 
phosphorylation of MAPK occurs in upstream of caspase 
signaling. We also found that phosphorylation of p38 
MAPK occurs independent of ERK1/2 since PD98059 did 
not inhibit phosphorylation of p38 MAPK (Fig. 4D). 
SB203580 did not inhibit phosphorylation of ERK either 
(Fig. 4D). PD98059 and SB203580 showed specificity 
since both inhibited phosphorylation of ERK1/2 and p38 
MAPK respectively. Interestingly, SB203580 increased 
basal level of phosphorylation of ERK1/2 significantly in 
AGS (Fig. 4D). This suggests that there is an intrinsic 
competition between p38 MAPK and ERK1/2 in response 
to camptothecin. To determine whether blocking of 
MAPK signaling affects caspase signaling, AGS was pre-
treated with SB203580 or PD98059 for 2 h, and campto-
thecin (1 µM) was added. As shown in Fig. 4E, blocking 
of p38 MAPK or ERK1/2 did not affect procaspase-8 
processing. However, SB203580 but not PD98059 par-
tially inhibited PARP cleavage by camptothecin in AGS. 
This is consistent with the fact that SB203580 attenuated 
cell death by camptothecin (Fig. 4A). This also suggests 
that MAPK signaling is at least partially related to cas-
pase signaling in AGS. Taken together, these data suggest 
that camptothecin employs MAPK signaling, and the ac-
tivation of it at least partially affects cell death, if not 
apoptotic cell death, by camptothecin in AGS.  
 
MAPK signaling affects p21 induction  In this study, we 
found that camptothecin induced p21 in a dose and time-
dependent manner (Figs. 5A and 5B). Induction of p21 by 
camptothecin was confirmed by cDNA microarray (data 
not shown). We also checked whether MAPK signaling 
affects p21 induction by camptothecin. As shown in Fig. 
5C, both SB203580 and PD98059 significantly inhibited 
p21 induction by camptothecin in AGS. This suggests that 
MAPK signaling is at least partially involved in induction 
of p21 by camptothecin in AGS.  
 
 
Discussion 
 
We characterized molecular mechanism of apoptotic cell 
death by camptothecin in human gastric cancer cell line. 
Camptothecin clearly induced apoptosis in AGS (Figs. 
1A−1D and Figs. 2A and 2B). Z-VAD-fmk but not z-
IETD-fmk (an inhibitor of caspase-8) prevented DNA 
fragmentation (Fig. 3A). Z-DEVD-fmk (an inhibitor of 
caspase-3) also prevented DNA fragmentation. Report-
edly, neuronal cell death by camptothecin was dependent 
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on p53, and was associated with increased expression of 
Apaf1 (Fortin et al., 2001). This suggests that caspase-9 is 
involved in neuronal cell death by camptothecin. In this 
study, we found that an inhibitor of caspase-9 did not af-
fect cell death by camptothecin (Fig. 3C). We did not de-
tect decrease in the level of caspase-9 or cleavage of it 
(data not shown). We found that various proteases inhibi-
tors did not affect camptothecin-induced cell death (Fig. 
3C). Among those caspases inhibitors, only Z-VAD-fmk 
prevented apoptotic cell death by camptothecin (Fig. 3B). 
We found that proteases inhibitors, including PMSF, in-
hibited apoptotic cell death by camptothecin based on 
annexin staining (Fig. 3B). Previously, it was reported 
that proteases inhibitors prevented DNA fragmentation 
induced by various anticancer drugs including camptothe-
cin in malignant glioma cells (Eitel et al., 1999). In this 
study, we found that proteases inhibitors did not affect 
cell death by camptothecin. However, some of these in-
hibitors attenuated apoptotic cell death (Fig. 3B).  
   In this study, we checked whether MAPK signaling was 
involved in camptothecin-induced cell death in AGS. We 
found that SB203580, an inhibitor of p38 MAPK phos-
phorylation, attenuated camptothecin-induced cell death 
in AGS (Fig. 4A). Camptothecin induced phosphorylation 
of ERK1/2, JNK, and p38 MAPK in AGS (Figs. 4B and 
4C). The fact that PD98059 did not affect phosphoryla-
tion of p38 MAPK or JNK suggests that phosphorylation 
of ERK1/2 occurs independent of phosphorylation of p38 
MAPK or JNK in AGS (Fig. 4D). Interestingly, we found 
that blocking of p38 MAPK induced basal level of phos-
phorylation of ERK1/2 significantly. Recently, it was re-
ported that blocking of p38 MAPK led to an increased 
phosphorylation of ERK1/2 (Ding and Adrian, 2001). 
Based on z-VAD-fmk treatment, MAPK signaling occurs 
upstream of caspases (Fig. 4D). This suggests that camp-
tothecin employs multiple signaling for its effect. 
SB203580 partially inhibited PARP cleavage in AGS (Fig. 
4E). This suggests that MAPK signaling at least partially 
affects apoptotic signaling in AGS. As far as we know, 
the involvement of MAPK signaling in camptothecin-
induced cell death has not been reported previously. Pre-
viously, it was reported that inhibitor of p38 MAPK or 
ERK1/2 did not affect cell death by camptothecin in hu-
man promonocytic cells (Galan et al., 2000). We carried 
out cDNA microarray analysis to identify genes that are 
altered in expression levels by camptothecin (Data not 
shown). We found that p21 is one of the most upregulated 
genes by camptothecin. Therefore, we carried out studies 
aimed at p21. Camptothecin induced p21 in a dose and 
time-dependent manner (Figs. 5A and 5B). The induction 
of p21 was also seen in many other gastric cancer cell 
lines. It was interesting to find that SB203580 signifi-
cantly decreased the amount of p21 induced by campto-
thecin in AGS (Fig. 5C). The involvement of p38 MAPK 
in p21 induction was reported on G (i) protein-coupled 
receptors (Alderton et al., 2001). ERK signaling pathway 
mediates the up-regulation of the p21 expression was re-
ported on differentiation of HL60 cells (Lee et al., 2002). 
PD98059 also inhibited induction of p21 by camptothecin. 
These data suggest that the induction of p21 by campto-
thecin is associated with MAPK signaling in AGS. The 
fact that reduced amount of p21 leads to attenuated cell 
death suggests that induction of p21 is indeed necessary 
for camptothecin-induced cell death in AGS. The direct 
role of p21 in camptothecin-induced cell death is not clear. 
It was reported that p21 was necessary for senescence, but 
not apoptosis, induced by camptothecin in human colon 
cancer cells (Han et al., 2002). In this study, we carried 
out antisense experiment and found that p21 did not affect 
cell death by camptothecin (data not shown). The rela-
tionship between MAPK signaling and p21 also needs 
further study. We checked whether camptothecin regu-
lated the expression level of p53. We did not detect the 
induction of p53 by camptothecin (data not shown). This 
suggests that the induction of p21 occurs independent of 
p53.  
   In summary, camptothecin induced apoptotic cell death 
that employed MAPK signaling in addition to caspases. 
After all, thorough dissection of biochemical and genetic 
pathways will be needed for understanding the role of 
MAPK signaling in camptothecin-induced cell death.  
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